Date: 2025-10-08Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2025/1649 of the European Parliament of 7 May 2025 on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023
**Executive Summary**
This document is Decision (EU) 2025/1649 of the European Parliament, dated 7 May 2025, concerning the discharge of the budget implementation of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023. It grants discharge to the Director of the Agency and includes observations to be detailed in a separate resolution. It was published in the Official Journal of the European Union on 8 October 2025.
**Key Points / Main Content**
* **Budget Discharge:**
* The Director of the European Union Drugs Agency is granted discharge in respect of the implementation of the Centre's budget for the financial year 2023.
* **Observations:**
* The European Parliament's observations regarding the discharge are outlined in a separate resolution.
* **Documentation Considered:**
* The European Parliament considered the final annual accounts of the Centre for the financial year 2023.
* The Parliament reviewed the Court of Auditors' annual report on EU agencies for 2023, along with the Agency's replies.
* The statement of assurance provided by the Court of Auditors for the financial year 2023 was taken into account.
* The Council’s recommendation of 17 February 2025 on discharge was considered.
* **Regulations and Rules Considered**
* Regulation (EU, Euratom) 2018/1046
* Regulation (EU, Euratom) 2024/2509
* Regulation (EC) No 1920/2006
* Regulation (EU) 2023/1322
* Commission Delegated Regulation (EU) 2019/715
* Rule 102 of and Annex V to its Rules of Procedure
* **Committee Opinions Considered:**
* The opinions of various committees, including Employment and Social Affairs, Environment, Climate and Food Safety, Transport and Tourism, Fisheries, Culture and Education, Civil Liberties, Justice and Home Affairs, and Women's Rights and Gender Equality, were taken into account.
* **Instruction:**
* The President of the European Parliament is instructed to forward the decision and related resolution to the Director of the European Union Drugs Agency, the Council, the Commission, and the Court of Auditors for publication in the Official Journal of the European Union (L series).
**Impact Analysis**
**Director of the European Union Drugs Agency**
* **Impact:** Granted discharge for the implementation of the Agency's budget in 2023.
* **Action Required:** Review the resolution containing the European Parliament's observations regarding the budget discharge.
**Council, Commission, Court of Auditors**
* **Impact:** Informed of the European Parliament's decision on the budget discharge.
* **Action Required:** Take note of the decision and any related observations in the resolution, arrange for the publication.
**European Parliament**
* **Impact:** Makes decision on budget discharge of the European Union Drugs Agency.
* **Action Required:** Ensure decision and resolution are forwarded and published.
Key Entities Referenced
European Union Drugs Agency: The former European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Agency responsible for monitoring and providing information on drugs and drug addiction in the EU.
Regulation (EU, Euratom) 2018/1046: Financial rules applicable to the general budget of the Union.
European Parliament: One of the primary entities issuing the Decision, responsible for granting discharge.
Court of Auditors: Audits the accounts and underlying transactions of EU agencies.
Treaty on the Functioning of the European Union: Referenced Treaty providing the basis for the decision, particularly Article 319.
Official Journal EN
of the European Union L series
2025/1649 8.10.2025
DECISION(EU) 2025/1649 OF THE EUROPEAN PARLIAMENT
of 7 May 2025
on discharge in respect of the implementation of the budget of the European Monitoring Centre for
Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Monitoring Centre for Drugs and Drug Addiction for the
financial year 2023,
— having regard to the Court of Auditors’ annual report on EU agencies for the financial year 2023, together with the
agencies’ replies(1),
— having regard to the statement of assurance(2)as to the reliability of the accounts and the legality and regularity of the
underlying transactions provided by the Court of Auditors for the financial year 2023, pursuant to Article 287 of the
Treaty on the Functioning of the European Union,
— having regard to the Council’s recommendation of 17 February 2025 on discharge to be given to the Centre in
respect of the implementation of the budget for the financial year 2023 (05755/2025 – C10-0024/2025),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012(3), and in particular Article 70 thereof,
— having regard to Regulation (EU, Euratom) 2024/2509 of the European Parliament and of the Council of
23 September 2024 on the financial rules applicable to the general budget of the Union(4), and in particular
Article 70 thereof,
— having regard to Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December
2006 on the European Monitoring Centre for Drugs and Drug Addiction(5), and in particular Article 15 thereof,
— having regard to Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the
European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006(6), and in particular Article 41
thereof,
— having regard to Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework
financial regulation for the bodies set up under the TFEU and Euratom Treaty and referred to in Article 70 of
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council(7), and in particular
Article 105 thereof,
— having regard to Rule 102 of and Annex V to its Rules of Procedure,
— having regard to the opinions of the Committee on Employment and Social Affairs, the Committee on the
Environment, Climate and Food Safety, the Committee on Transport and Tourism, the Committee on Fisheries, the
Committee on Culture and Education, the Committee on Civil Liberties, Justice and Home Affairs, and the
Committee on Women’s Rights and Gender Equality,
— having regard to the report of the Committee on Budgetary Control (A10-0065/2025),
1. Grants the Director of European Union Drugs Agency discharge in respect of the implementation of the Centre’s
budget for the financial year 2023;
2. Sets out its observations in the resolution below;
(1) OJ C, C/2024/6332, 24.10.2024, ELI: http://data.europa.eu/eli/C/2024/6332/oj.
(2) OJ C, C/2024/6041, 10.10.2024, ELI: http://data.europa.eu/eli/C/2024/6041/oj.
(3) OJ L 193, 30.7.2018, p. 1, ELI: http://data.europa.eu/eli/reg/2018/1046/oj.
(4) OJ L, 2024/2509, 26.9.2024, ELI: http://data.europa.eu/eli/reg/2024/2509/oj.
(5) OJ L 376, 27.12.2006, p. 1, ELI: http://data.europa.eu/eli/reg/2006/1920/oj.
(6) OJ L 166, 30.6.2023, p. 6, ELI: http://data.europa.eu/eli/reg/2023/1322/oj.
(7) OJ L 122, 10.5.2019, p. 1, ELI: http://data.europa.eu/eli/reg_del/2019/715/oj.
ELI: http://data.europa.eu/eli/dec/2025/1649/oj 1/2EN
OJ L, 8.10.2025
3. Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Director of
European Union Drugs Agency, the Council, the Commission and the Court of Auditors, and to arrange for their
publication in the Official Journal of the European Union(L series).
The President The Secretary-General
Roberta METSOLA Alessandro CHIOCCHETTI
2/2 ELI: http://data.europa.eu/eli/dec/2025/1649/oj